Development of a Sensitive Anti-Human CCR9 Monoclonal Antibody (C<sub>9</sub>Mab-11) by N-Terminal Peptide Immunization-Reference-Cited by-同舟云学术

Development of a Sensitive Anti-Human CCR9 Monoclonal Antibody (C₉Mab-11) by N-Terminal Peptide Immunization

Published:2022-12-01 Issue:6 Volume:41 Page:303-310
ISSN:2167-9436
Container-title:Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
language:en
Short-container-title:Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

Author:

Tanaka Tomohiro¹,Suzuki Hiroyuki²,Isoda Yu¹,Asano Teizo¹,Nakamura Takuro¹,Yanaka Miyuki¹,Handa Saori¹,Takahashi Nozomi¹,Okuno Saori¹,Yoshikawa Takeo³^ORCID,Li Guanjie²,Nanamiya Ren¹,Goto Nohara²,Tateyama Nami¹,Okada Yuki²,Kobayashi Hiyori²,Kaneko Mika K.¹,Kato Yukinari¹²³^ORCID

Affiliation:

1. Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.

2. Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Japan.

3. Department of Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Immunology,Immunology and Allergy

Link

https://www.liebertpub.com/doi/pdf/10.1089/mab.2022.0027

Reference51 articles.

1. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

2. Chemokines and the immune response to cancer

3. CCR9 in cancer: oncogenic role and therapeutic targeting

4. Complex regulation of CCR9 at multiple discrete stages of T cell development

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of a Novel Anti-Human CCR6 Monoclonal Antibody C₆Mab-19 with the High Binding Affinity in Flow Cytometry;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2023-08-01

2. Epitope Mapping of the Novel Anti-Human CCR9 Monoclonal Antibody (C₉Mab-11) by 2 × Alanine Scanning;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2023-04-01

3. Determination of the Binding Epitope of an Anti-Mouse CCR9 Monoclonal Antibody (C9Mab-24) Using the 1× Alanine and 2× Alanine-Substitution Method;Antibodies;2023-01-31